BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 9034265)

  • 1. Differential effects of nitric oxide synthase modulation on porcine systemic and pulmonary circulation in vivo.
    Dahm P; Thörne J; Zoucas E; Mårtensson L; Myhre E; Blomquist S
    Crit Care Med; 1997 Feb; 25(2):280-5. PubMed ID: 9034265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis.
    Strand OA; Leone AM; Giercksky KE; Skovlund E; Kirkebøen KA
    Crit Care Med; 1998 Sep; 26(9):1490-9. PubMed ID: 9751584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of nitric oxide synthase inhibitors on acetylcholine-induced relaxation of rat pulmonary and celiac artery rings.
    Yaghi A; Paterson NA; McCormack DG
    Can J Physiol Pharmacol; 1997 Apr; 75(4):279-86. PubMed ID: 9196853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans.
    Blitzer ML; Loh E; Roddy MA; Stamler JS; Creager MA
    J Am Coll Cardiol; 1996 Sep; 28(3):591-6. PubMed ID: 8772744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats.
    Granstam SO; Lind L; Granstam E; Fellström B
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):693-701. PubMed ID: 9750958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of NG-nitro-L-arginine-methyl-ester on cardiopulmonary function and biosynthesis of cyclooxygenase products during porcine endotoxemia.
    Hellyer PW; Johnson LW; Olson NC
    Crit Care Med; 1997 Jun; 25(6):1051-8. PubMed ID: 9201060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.
    Stamler JS; Loh E; Roddy MA; Currie KE; Creager MA
    Circulation; 1994 May; 89(5):2035-40. PubMed ID: 7514109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep.
    Booke M; Hinder F; McGuire R; Traber LD; Traber DL
    Crit Care Med; 1996 May; 24(5):835-44. PubMed ID: 8706462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.
    Joshi S; Young WL; Duong DH; Ostapkovich ND; Aagaard BD; Hashimoto T; Pile-Spellman J
    Anesthesiology; 2000 Sep; 93(3):699-707. PubMed ID: 10969303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production.
    Guazzi M; Arena R; Vicenzi M; Guazzi MD
    Acta Physiol (Oxf); 2009 Jun; 196(2):267-77. PubMed ID: 19032601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide contributes to substance P-induced increases in lung rapidly adapting receptor activity in guinea-pigs.
    Joad JP; Kott KS; Bonham AC
    J Physiol; 1997 Sep; 503 ( Pt 3)(Pt 3):635-43. PubMed ID: 9379417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.
    Dawes M; Chowienczyk PJ; Ritter JM
    Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide in the hemodynamic changes of sepsis.
    Lorente JA; Landín L; Renes E; De Pablo R; Jorge P; Ródena E; Liste D
    Crit Care Med; 1993 May; 21(5):759-67. PubMed ID: 8482098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
    Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
    Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans.
    Rongen GA; Smits P; Thien T
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.